Survodutide

What it is claimed to help

These are the uses attached to Survodutide in research, clinical practice, or marketing. Listing a claim is not endorsing it — tap any of them to see every other compound carrying the same claim.

What the human evidence actually is

Phase 2 in NEJM (2024) reported biopsy-confirmed improvement in MASH in the majority of treated patients, with fibrosis improvement in a substantial fraction — a harder endpoint than liver fat alone. Phase 3 ongoing. Not approved.

How it is supposed to work

Glucagon receptor agonism raises energy expenditure and acts directly on hepatocytes; GLP-1 agonism suppresses appetite.

Safety

GI effects; the glucagon component complicates glycaemic effects. No long-term data.

Storage and handling

Lyophilised peptide is generally stored at 2–8 °C, or below −20 °C for long-term storage. Reconstituted in bacteriostatic water (0.9% benzyl alcohol) a solution is typically treated as usable for about 28 days refrigerated, versus roughly 24 hours for plain sterile water, which has no preservative. Add the water slowly down the vial wall and swirl — never shake, which shears peptide chains and foams the solution.